ST. LOUIS--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced the appointment of the research and development (R&D) leadership team for its Pharmaceutical Products and Imaging Solutions businesses.
